Quest Diagnostics Files 2023 10-K

TL;DR

**Quest Diagnostics just dropped its 2023 10-K, giving us the full financial picture for the year.**

AI Summary

Quest Diagnostics Inc. filed its 10-K on February 22, 2024, for the fiscal year ended December 31, 2023. The filing includes financial data and corporate information, with its business address at 500 Plaza Drive, Secaucus, NJ. Key personnel mentioned include Karthikeyan Kuppusamy and Catherine Doherty, with their roles spanning the fourth quarter of 2023.

Why It Matters

This filing provides a comprehensive overview of Quest Diagnostics' financial health and operational performance for 2023, crucial for investors and stakeholders to assess its stability and future prospects.

Risk Assessment

Risk Level: medium — The filing itself doesn't detail specific risks, but as a 10-K, it's a standard disclosure document for a publicly traded company, implying inherent market and operational risks.

Key Numbers

• 2023-12-31 — Fiscal Year End (Indicates the period covered by the financial report.)
• 001-12215 — SEC File Number (Unique identifier for the company's filings with the SEC.)
• 113 — Public Document Count (Number of documents included in the filing.)
• 0001022079 — Central Index Key (CIK) (Unique identifier for the company in the SEC's EDGAR system.)
• 1996-09-03 — Date of Name Change (When the company changed its name from Corning Clinical Laboratories Inc.)

Key Players & Entities

• QUEST DIAGNOSTICS INC (company) — Filer
• Karthikeyan Kuppusamy (person) — Member mentioned in Q4 2023
• Catherine Doherty (person) — Member mentioned in Q4 2023
• 500 Plaza Drive, Secaucus, NJ (company) — Business Address
• December 31, 2023 (date) — Conformed Period of Report

FAQ

From the Filing

0001022079-24-000041.txt : 20240222 0001022079-24-000041.hdr.sgml : 20240222 20240222161800 ACCESSION NUMBER: 0001022079-24-000041 CONFORMED SUBMISSION TYPE: 10-K PUBLIC DOCUMENT COUNT: 113 CONFORMED PERIOD OF REPORT: 20231231 FILED AS OF DATE: 20240222 DATE AS OF CHANGE: 20240222 FILER: COMPANY DATA: COMPANY CONFORMED NAME: QUEST DIAGNOSTICS INC CENTRAL INDEX KEY: 0001022079 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MEDICAL LABORATORIES [8071] ORGANIZATION NAME: 08 Industrial Applications and Services IRS NUMBER: 161387862 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-12215 FILM NUMBER: 24665046 BUSINESS ADDRESS: STREET 1: 500 PLAZA DRIVE CITY: SECAUCUS STATE: NJ ZIP: 07094 BUSINESS PHONE: 9735202700 MAIL ADDRESS: STREET 1: 500 PLAZA DRIVE CITY: SECAUCUS STATE: NJ ZIP: 07094 FORMER COMPANY: FORMER CONFORMED NAME: CORNING CLINICAL LABORATORIES INC DATE OF NAME CHANGE: 19960903 10-K 1 dgx-20231231.htm 10-K dgx-20231231 0001022079 2023 FY FALSE 363 345 P5Y P5Y P5Y 31.5 http://fasb.org/us-gaap/2023#OperatingLeaseRightOfUseAsset http://fasb.org/us-gaap/2023#OperatingLeaseRightOfUseAsset http://fasb.org/us-gaap/2023#AccountsPayableAndAccruedLiabilitiesCurrent http://fasb.org/us-gaap/2023#AccountsPayableAndAccruedLiabilitiesCurrent http://fasb.org/us-gaap/2023#OtherLiabilitiesNoncurrent http://fasb.org/us-gaap/2023#OtherLiabilitiesNoncurrent http://fasb.org/us-gaap/2023#LongTermDebtAndCapitalLeaseObligations http://fasb.org/us-gaap/2023#LongTermDebtAndCapitalLeaseObligations 0001022079 2023-01-01 2023-12-31 0001022079 2023-06-30 iso4217:USD 0001022079 2024-02-01 xbrli:shares 0001022079 2023-12-31 0001022079 dgx:KarthikeyanKuppusamyMember 2023-10-01 2023-12-31 0001022079 dgx:CatherineDohertyMember 2023-10-01 2023-12-31 0001022079 2023-10-01 2023-12-31 0001022079 dgx:KarthikeyanKuppusamyMember 2023-12-31 0001022079 dgx:CatherineDohertyMember 2023-12-31 0001022079 2022-12-31 iso4217:USD xbrli:shares 0001022079 2022-01-01 2022-12-31 0001022079 2021-01-01 2021-12-31 0001022079 2021-12-31 0001022079 2020-12-31 0001022079 us-gaap:CommonStockMember 2020-12-31 0001022079 us-gaap:AdditionalPaidInCapitalMember 2020-12-31 0001022079 us-gaap:RetainedEarningsMember 2020-12-31 0001022079 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-12-31 0001022079 us-gaap:TreasuryStockCommonMember 2020-12-31 0001022079 us-gaap:NoncontrollingInterestMember 2020-12-31 0001022079 us-gaap:RetainedEarningsMember 2021-01-01 2021-12-31 0001022079 us-gaap:NoncontrollingInterestMember 2021-01-01 2021-12-31 0001022079 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-01-01 2021-12-31 0001022079 us-gaap:AdditionalPaidInCapitalMember 2021-01-01 2021-12-31 0001022079 us-gaap:TreasuryStockCommonMember 2021-01-01 2021-12-31 0001022079 us-gaap:CommonStockMember 2021-01-01 2021-12-31 0001022079 us-gaap:CommonStockMember 2021-12-31 0001022079 us-gaap:AdditionalPaidInCapitalMember 2021-12-31 0001022079 us-gaap:RetainedEarningsMember 2021-12-31 0001022079 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-12-31 0001022079 us-gaap:TreasuryStockCommonMember 2021-12-31 0001022079 us-gaap:NoncontrollingInterestMember 2021-12-31 0001022079 us-gaap:RetainedEarningsMember 2022-01-01 2022-12-31 0001022079 us-gaap:NoncontrollingInterestMember 2022-01-01 2022-12-31 0001022079 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-01-01 2022-12-31 0001022079 us-gaap:CommonStockMember 2022-01-01 2022-12-31 0001022079 us-gaap:AdditionalPaidInCapitalMember 2022-01-01 2022-12-31 0001022079 us-gaap:TreasuryStockCommonMember 2022-01-01 2022-12-31 0001022079 us-gaap:CommonStockMember 2022-12-31 0001022079 us-gaap:AdditionalPaidInCapitalMember 2022-12-31 0001022079 us-gaap:RetainedEarningsMember 2022-12-31 0001022079 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-12-31 0001022079 us-gaap:TreasuryStockCommonMember 2022-12-31 0001022079 us-gaap:NoncontrollingInterestMember 2022-12-31 0001022079 us-gaap